Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (200)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
40
2025
2999
2.840
Why?
High-Throughput Nucleotide Sequencing
7
2022
174
1.110
Why?
Genomics
10
2023
265
0.830
Why?
Mutation
14
2022
1318
0.820
Why?
Software
4
2021
280
0.810
Why?
Plasma Cells
7
2025
234
0.740
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
120
0.630
Why?
Tumor Microenvironment
4
2024
246
0.580
Why?
Clonal Evolution
4
2020
59
0.550
Why?
Computational Biology
4
2020
209
0.520
Why?
Gene Expression Regulation, Neoplastic
6
2024
853
0.500
Why?
Algorithms
4
2020
663
0.470
Why?
Neoplasm Recurrence, Local
5
2024
630
0.450
Why?
Humans
48
2025
52114
0.400
Why?
Prognosis
13
2025
2093
0.400
Why?
Neoplasms
2
2020
1288
0.380
Why?
Translocation, Genetic
7
2022
265
0.380
Why?
Gene Expression Profiling
10
2025
1101
0.380
Why?
Positron-Emission Tomography
3
2025
297
0.380
Why?
Hematopoietic Stem Cell Transplantation
3
2024
597
0.370
Why?
Osteolysis
2
2022
74
0.360
Why?
Models, Molecular
1
2013
351
0.360
Why?
Diffusion Magnetic Resonance Imaging
2
2025
132
0.360
Why?
Chromosome Aberrations
3
2023
295
0.340
Why?
Genome, Human
3
2021
121
0.340
Why?
Evolution, Molecular
2
2021
95
0.340
Why?
Osteocytes
2
2024
225
0.330
Why?
Signal Transduction
4
2024
1699
0.330
Why?
Proteins
1
2013
347
0.320
Why?
Bone Marrow
3
2020
361
0.300
Why?
Epigenomics
2
2021
74
0.290
Why?
Disease Progression
8
2025
866
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1020
0.260
Why?
RANK Ligand
2
2024
187
0.250
Why?
Gene Rearrangement
2
2023
76
0.230
Why?
Oncogenes
3
2021
60
0.230
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
HMGB1 Protein
1
2024
21
0.220
Why?
Chemokine CXCL12
1
2024
34
0.220
Why?
Bone Resorption
2
2024
302
0.210
Why?
Burkitt Lymphoma
1
2023
27
0.200
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
12
0.200
Why?
Gene Dosage
2
2020
76
0.200
Why?
Neoplasm, Residual
2
2025
170
0.190
Why?
Epigenesis, Genetic
3
2023
401
0.190
Why?
Proto-Oncogene Proteins c-akt
1
2023
170
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
77
0.190
Why?
Drug Resistance, Neoplasm
1
2024
324
0.190
Why?
Neoplasm Proteins
2
2021
328
0.180
Why?
Cell Communication
1
2022
72
0.180
Why?
Mice
8
2024
5877
0.180
Why?
Telomere Homeostasis
1
2021
11
0.180
Why?
Transcriptome
3
2025
363
0.180
Why?
Polycomb Repressive Complex 2
1
2021
48
0.170
Why?
Ubiquitination
1
2021
57
0.170
Why?
Chromosome Deletion
2
2023
139
0.170
Why?
Loss of Heterozygosity
2
2018
78
0.170
Why?
Lymphoma, B-Cell
1
2021
61
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Sequence Analysis, DNA
2
2018
219
0.160
Why?
Cell Cycle
1
2021
237
0.160
Why?
Cell Cycle Proteins
1
2021
167
0.160
Why?
B-Lymphocytes
1
2021
180
0.160
Why?
Female
13
2025
28055
0.160
Why?
Lymphoma, Follicular
1
2020
27
0.160
Why?
Cell Line, Tumor
4
2024
1418
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Aged
10
2025
10142
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Genes, myc
1
2019
39
0.150
Why?
Middle Aged
10
2025
13028
0.150
Why?
Aged, 80 and over
6
2025
3382
0.150
Why?
Tumor Suppressor Protein p53
2
2017
224
0.150
Why?
Transplantation, Autologous
4
2024
480
0.140
Why?
Mutagenesis
1
2018
60
0.140
Why?
Genome
1
2018
60
0.140
Why?
Male
13
2025
26652
0.140
Why?
Homologous Recombination
1
2018
41
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Flow Cytometry
1
2018
397
0.130
Why?
Survival Rate
4
2021
945
0.130
Why?
Animals
8
2024
13332
0.130
Why?
DNA Repair
1
2018
194
0.130
Why?
Adult
8
2025
14095
0.120
Why?
DNA Copy Number Variations
3
2022
117
0.120
Why?
Remission Induction
3
2021
218
0.120
Why?
Genes, Neoplasm
1
2015
31
0.110
Why?
Pattern Recognition, Automated
1
2015
39
0.110
Why?
Cluster Analysis
1
2015
236
0.110
Why?
Follow-Up Studies
4
2021
2282
0.110
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
120
0.100
Why?
Amino Acid Sequence
1
2013
566
0.090
Why?
T-Lymphocytes
2
2024
316
0.090
Why?
Chromatin
2
2023
141
0.090
Why?
Breast Neoplasms
1
2020
1199
0.090
Why?
Adenocarcinoma
1
2015
401
0.090
Why?
Mutation Rate
2
2021
36
0.080
Why?
In Situ Hybridization, Fluorescence
2
2023
262
0.080
Why?
Tumor Burden
2
2020
133
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Clone Cells
2
2021
76
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
68
0.080
Why?
Histones
2
2021
316
0.070
Why?
DNA, Neoplasm
2
2020
146
0.070
Why?
Lung Neoplasms
1
2015
624
0.070
Why?
DNA Mutational Analysis
2
2020
179
0.070
Why?
Treatment Outcome
4
2020
5456
0.070
Why?
DNA Methylation
2
2023
583
0.070
Why?
Recurrence
2
2021
680
0.070
Why?
Genomic Instability
2
2018
89
0.070
Why?
Risk Factors
3
2021
3922
0.060
Why?
Cell Proliferation
2
2021
1017
0.060
Why?
ROC Curve
1
2025
250
0.060
Why?
Internet
2
2018
260
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
112
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
128
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
216
0.050
Why?
Antibodies
1
2024
148
0.050
Why?
Proteasome Inhibitors
1
2024
101
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Oxidative Phosphorylation
1
2023
45
0.050
Why?
B-Cell Maturation Antigen
1
2024
92
0.050
Why?
Cytogenetic Analysis
1
2023
79
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
17
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
95
0.050
Why?
Immunoglobulins
1
2023
76
0.050
Why?
Forkhead Transcription Factors
1
2023
119
0.050
Why?
Retrospective Studies
2
2025
6610
0.050
Why?
Phylogeny
1
2022
229
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
Spliceosomes
1
2021
10
0.040
Why?
Transcriptional Activation
1
2021
128
0.040
Why?
RNA Splicing
1
2021
41
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Alternative Splicing
1
2021
61
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
63
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Phosphoproteins
1
2021
120
0.040
Why?
Ecosystem
1
2021
96
0.040
Why?
Single-Cell Analysis
1
2020
71
0.040
Why?
Mice, Transgenic
1
2021
560
0.040
Why?
DNA
1
2023
543
0.040
Why?
Cell Differentiation
1
2022
670
0.040
Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
Why?
Melphalan
1
2020
178
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Neoplasm Invasiveness
1
2020
277
0.040
Why?
Genetic Variation
1
2020
224
0.040
Why?
Osteogenesis
1
2022
365
0.040
Why?
Combined Modality Therapy
1
2021
634
0.040
Why?
Multivariate Analysis
1
2021
600
0.040
Why?
Disease Models, Animal
1
2024
1467
0.040
Why?
Maintenance Chemotherapy
1
2019
50
0.040
Why?
Apoptosis
1
2024
1117
0.040
Why?
Cell Survival
1
2020
596
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.030
Why?
Reproducibility of Results
1
2021
1214
0.030
Why?
Genome-Wide Association Study
1
2018
184
0.030
Why?
Information Dissemination
1
2018
85
0.030
Why?
STAT3 Transcription Factor
1
2017
86
0.030
Why?
Fibroblast Growth Factors
1
2017
49
0.030
Why?
Prospective Studies
1
2023
2424
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1368
0.030
Why?
Thalidomide
1
2019
377
0.030
Why?
Proportional Hazards Models
1
2018
439
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
482
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Cohort Studies
1
2020
1541
0.030
Why?
Models, Genetic
1
2016
173
0.030
Why?
Antineoplastic Agents
1
2024
1214
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
149
0.030
Why?
Survival Analysis
1
2017
667
0.030
Why?
Stem Cell Transplantation
1
2016
186
0.030
Why?
Dogs
1
2015
182
0.030
Why?
Databases, Genetic
1
2015
82
0.030
Why?
Time Factors
1
2021
2970
0.030
Why?
Sequence Analysis, RNA
1
2015
96
0.030
Why?
Genetic Testing
1
2015
130
0.030
Why?
Longitudinal Studies
1
2016
742
0.030
Why?
Child
1
2023
7147
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description